Hannah Sharpe

12.8k total citations
12 papers, 305 citations indexed

About

Hannah Sharpe is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Hannah Sharpe has authored 12 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Hannah Sharpe's work include SARS-CoV-2 and COVID-19 Research (3 papers), Viral gastroenteritis research and epidemiology (3 papers) and Viral Infections and Vectors (3 papers). Hannah Sharpe is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Viral gastroenteritis research and epidemiology (3 papers) and Viral Infections and Vectors (3 papers). Hannah Sharpe collaborates with scholars based in United Kingdom, United States and Australia. Hannah Sharpe's co-authors include Teresa Lambe, Ciarán Gilbride, Sandra Belij‐Rammerstorfer, Elizabeth Allen, Cameron Bissett, Katie Ewer, Georgina Bowyer, Sarah C. Gilbert, Simon Brackenridge and Marta Ulaszewska and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Hepatology.

In The Last Decade

Hannah Sharpe

12 papers receiving 298 citations

Peers

Countries citing papers authored by Hannah Sharpe

Since Specialization

Citations

This map shows the geographic impact of Hannah Sharpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Sharpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Sharpe more than expected).

Fields of papers citing papers by Hannah Sharpe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Sharpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Sharpe. The network helps show where Hannah Sharpe may publish in the future.

Co-authorship network of co-authors of Hannah Sharpe

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Sharpe. A scholar is included among the top collaborators of Hannah Sharpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Sharpe. Hannah Sharpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse 2024 ·PLoS Pathogens ·Amy Flaxman, Sarah Sebastian, Sofia Appelberg, (unknown), Marta Ulaszewska, Jyothi N. Purushotham, Ciarán Gilbride, Hannah Sharpe, Alexandra J. Spencer, Sagida Bibi, Daniel Wright, (unknown), Stuart Dowall, Linda Easterbrook, Stephen Findlay‐Wilson, Sarah C. Gilbert, Alì Mirazimi, Teresa Lambe	8
2	IL-12 drives the differentiation of human T follicular regulatory cells 2024 ·Science Immunology ·Diana Castaño, Sidney Wang, (unknown), (unknown), (unknown), Hannah Sharpe, Jacinta Bustamante, Allan Feng, Carole Le Coz, Neil Romberg, John W. Tobias, Paul J. Utz, Sarah E. Henrickson, Jean‐Laurent Casanova, Roberto Bonasio, Michela Locci	9
3	Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine 2024 ·npj Vaccines ·Cameron Bissett, Sandra Belij‐Rammerstorfer, Marta Ulaszewska, Holly Smith, Reshma Kailath, Susan Morris, Claire Powers, Sarah Sebastian, Hannah Sharpe, Elizabeth Allen, Ziyin Wang, (unknown), Hadijatou Sallah, Alexandra J. Spencer, Sarah C. Gilbert, John S. Tregoning, Teresa Lambe	8
4	A combined fine needle aspiration and spectral flow cytometry approach to assess human germinal center responses to SARS-CoV-2 vaccination 2022 ·STAR Protocols ·Emily Bettini, Katlyn Lederer, Hannah Sharpe, Mary Kaminski, Lisa P. Jones, Michela Locci	5
5	CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination 2022 ·JCI Insight ·Hannah Sharpe, Nicholas M. Provine, Georgina Bowyer, Pedro M. Folegatti, Sandra Belij‐Rammerstorfer, Amy Flaxman, Rebecca Makinson, Adrian V. S. Hill, Katie Ewer, Andrew J. Pollard, Paul Klenerman, Sarah C. Gilbert, Teresa Lambe	8
6	Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice 2021 ·Nature Communications ·Alexandra J. Spencer, Paul F. McKay, Sandra Belij‐Rammerstorfer, Marta Ulaszewska, Cameron Bissett, Kai Hu, Karnyart Samnuan, Anna K. Blakney, Daniel Wright, Hannah Sharpe, Ciarán Gilbride, Adam Truby, Elizabeth Allen, Sarah C. Gilbert, Robin J. Shattock, Teresa Lambe	87
7	The Integration of Human and Veterinary Studies for Better Understanding and Management of Crimean-Congo Haemorrhagic Fever 2021 ·Frontiers in Immunology ·Ciarán Gilbride, (unknown), Hannah Sharpe, (unknown), Georgina Limon, Anna B. Ludi, Teresa Lambe, Sandra Belij‐Rammerstorfer	10
8	The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world 2020 ·Immunology ·Hannah Sharpe, Ciarán Gilbride, Elizabeth Allen, Sandra Belij‐Rammerstorfer, Cameron Bissett, Katie Ewer, Teresa Lambe	79
9	Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cells 2020 ·The Journal of Experimental Medicine ·Georgina Bowyer, Hannah Sharpe, Navin Venkatraman, (unknown), Djibril Wade, Nicole Brenner, Alexander J. Mentzer, Catherine Mair, Tim Waterboer, Teresa Lambe, Tandakha N. Dieye, Souleymane Mboup, Adrian V. S. Hill, Katie Ewer	30
10	A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector 2020 ·Vaccines ·Sarah Sebastian, Amy Flaxman, (unknown), Marta Ulaszewska, Ciarán Gilbride, Hannah Sharpe, Edward Wright, Alexandra J. Spencer, Stuart Dowall, Roger Hewson, Sarah C. Gilbert, Teresa Lambe	11
11	HLA-E: exploiting pathogen-host interactions for vaccine development 2019 ·Clinical & Experimental Immunology ·Hannah Sharpe, Georgina Bowyer, Simon Brackenridge, Teresa Lambe	26
12	Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus 2019 ·Hepatology ·Erwan Atcheson, Wenqin Li, Carly M. Bliss, Senthil Chinnakannan, Kathrin Heim, Hannah Sharpe, Claire Hutchings, Isabelle Dietrich, Dung Nguyen, Amit Kapoor, Michael A. Jarvis, Paul Klenerman, Eleanor Barnes, Peter Simmonds	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact